EBITDA Summary of Sino Biopharmaceutical Limited

Sino Biopharmaceutical Limited's latest annual EBITDA in 2023 was 6.97 Billion CNY , down -9.19% from previous year.
Sino Biopharmaceutical Limited's latest quarterly EBITDA in 2024 Q1 was 1.97 Billion CNY , down 0.0% from previous quarter.
Sino Biopharmaceutical Limited reported an annual EBITDA of 6.69 Billion CNY in 2022, down -61.03% from previous year.
Sino Biopharmaceutical Limited reported an annual EBITDA of 19.87 Billion CNY in 2021, up 203.41% from previous year.
Sino Biopharmaceutical Limited reported a quarterly EBITDA of 1.97 Billion CNY for 2024 Q2, down 0.0% from previous quarter.
Sino Biopharmaceutical Limited reported a quarterly EBITDA of 1.86 Billion CNY for 2023 Q2, down 0.0% from previous quarter.

Annual EBITDA Chart of Sino Biopharmaceutical Limited (2023 - 1999)

Historical Annual EBITDA of Sino Biopharmaceutical Limited (2023 - 1999)

Year	EBITDA	EBITDA Growth
2023	6.97 Billion CNY	-9.19%
2022	6.69 Billion CNY	-61.03%
2021	19.87 Billion CNY	203.41%
2020	6.54 Billion CNY	-10.05%
2019	7.36 Billion CNY	18.29%
2018	6.14 Billion CNY	36.12%
2017	4.61 Billion CNY	19.45%
2016	3.59 Billion CNY	17.45%
2015	3.24 Billion CNY	31.63%
2014	2.48 Billion CNY	34.73%
2013	1.84 Billion CNY	14.73%
2012	1.53 Billion CNY	71.09%
2011	925.05 Million CNY	-7.93%
2010	1 Billion CNY	32.31%
2009	759.39 Million CNY	32.49%
2008	573.15 Million CNY	63.67%
2007	350.22 Million CNY	52.3%
2006	229.93 Million CNY	21.14%
2005	189.8 Million CNY	-38.13%
2004	306.79 Million CNY	56.5%
2003	196.03 Million CNY	22.81%
2002	159.62 Million CNY	25.8%
2001	140.76 Million CNY	35.71%
2000	92.95 Million CNY	34.84%
1999	69.34 Million CNY	0.0%

Year	EBITDA	EBITDA Growth
2024 Q1	1.97 Billion CNY	0.0%
2024 Q2	1.97 Billion CNY	0.0%
2023 Q2	1.86 Billion CNY	0.0%
2023 Q1	1.86 Billion CNY	68.15%
2023 Q3	- HKD	-100.0%
2023 FY	- CNY	-9.19%
2022 Q3	1.6 Billion CNY	-9.19%
2022 Q2	1.76 Billion CNY	0.0%
2022 Q1	1.76 Billion CNY	74.0%
2022 FY	- CNY	-61.03%
2022 Q4	1.11 Billion CNY	-30.81%
2021 Q2	1.97 Billion CNY	21.16%
2021 Q3	1.01 Billion CNY	-48.63%
2021 Q4	1.01 Billion CNY	0.0%
2021 FY	- CNY	203.41%
2021 Q1	1.63 Billion CNY	78.57%
2020 Q4	914.5 Million CNY	-26.74%
2020 Q2	1.53 Billion CNY	28.08%
2020 FY	- CNY	-10.05%
2020 Q1	1.19 Billion CNY	-2.17%
2020 Q3	1.24 Billion CNY	-18.45%
2019 Q4	1.22 Billion CNY	-35.15%
2019 FY	- CNY	18.29%
2019 Q1	1.25 Billion CNY	90.19%
2019 Q3	1.88 Billion CNY	29.66%
2019 Q2	1.45 Billion CNY	16.17%
2018 Q4	657.48 Million CNY	-66.48%
2018 FY	- CNY	36.12%
2018 Q1	1.03 Billion CNY	-18.09%
2018 Q2	1.31 Billion CNY	27.41%
2018 Q3	1.96 Billion CNY	48.68%
2017 Q4	1.26 Billion CNY	-1.71%
2017 Q3	1.28 Billion CNY	44.44%
2017 Q2	890.28 Million CNY	21.26%
2017 FY	- CNY	19.45%
2017 Q1	734.19 Million CNY	-22.99%
2016 Q4	953.38 Million CNY	-11.28%
2016 Q1	587.02 Million CNY	-25.36%
2016 FY	- CNY	17.45%
2016 Q2	814.07 Million CNY	38.68%
2016 Q3	1.07 Billion CNY	32.01%
2015 Q4	786.45 Million CNY	-21.4%
2015 Q1	505.46 Million CNY	-17.25%
2015 Q3	1 Billion CNY	41.26%
2015 FY	- CNY	31.63%
2015 Q2	708.32 Million CNY	40.13%
2014 Q1	420.01 Million CNY	-8.35%
2014 Q4	610.84 Million CNY	-18.15%
2014 Q3	746.25 Million CNY	50.06%
2014 Q2	497.31 Million CNY	18.4%
2014 FY	- CNY	34.73%
2013 Q4	458.28 Million CNY	-13.88%
2013 FY	- CNY	14.73%
2013 Q1	340.5 Million CNY	-15.82%
2013 Q2	340.47 Million CNY	-0.01%
2013 Q3	532.17 Million CNY	56.31%
2012 FY	- CNY	71.09%
2012 Q4	404.5 Million CNY	-7.26%
2012 Q3	436.14 Million CNY	36.13%
2012 Q1	287.18 Million CNY	12.48%
2012 Q2	320.38 Million CNY	11.56%
2011 Q1	189.34 Million CNY	0.0%
2011 Q2	198.11 Million CNY	4.63%
2011 Q3	172.24 Million CNY	-13.06%
2011 Q4	255.32 Million CNY	48.24%
2011 FY	- CNY	-7.93%
2010 Q1	171.81 Million CNY	0.0%
2010 Q2	174.99 Million CNY	1.85%
2010 FY	- CNY	32.31%
2009 FY	- CNY	32.49%
2008 FY	- CNY	63.67%
2007 FY	- CNY	52.3%
2006 FY	- CNY	21.14%
2005 FY	- CNY	-38.13%
2004 FY	- CNY	56.5%
2003 FY	- CNY	22.81%
2002 FY	- CNY	25.8%
2001 FY	- CNY	35.71%
2000 FY	- CNY	34.84%
1999 FY	- CNY	0.0%

Peer EBITDA Comparison of Sino Biopharmaceutical Limited

Name	EBITDA	EBITDA Difference
Uni-Bio Science Group Limited	91.23 Million HKD	-7550.028%
CK Life Sciences Int'l., (Holdings) Inc.	486.79 Million HKD	-1333.748%

Global Stocks Search

Sino Biopharmaceutical Limited (1177.HK)

EBITDA Summary of Sino Biopharmaceutical Limited

Annual EBITDA Chart of Sino Biopharmaceutical Limited (2023 - 1999)

Historical Annual EBITDA of Sino Biopharmaceutical Limited (2023 - 1999)

Peer EBITDA Comparison of Sino Biopharmaceutical Limited